-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, S/0O3Kxy3KqI5Le8TVptuiuTIir00htnuw8O+2jAITgBy+FelbKXrzltsbS88zkC cssiur8nMwSY8X1YIjw1jQ== 0001140361-10-011221.txt : 20100310 0001140361-10-011221.hdr.sgml : 20100310 20100310181512 ACCESSION NUMBER: 0001140361-10-011221 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100303 FILED AS OF DATE: 20100310 DATE AS OF CHANGE: 20100310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McGuinness Michael CENTRAL INDEX KEY: 0001304506 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 10671773 MAIL ADDRESS: STREET 1: C/O VYTERIS, INC. 13-01 POLLITT DRIVE CITY: FAIR LAWN STATE: NJ ZIP: 07410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 810 SEVENTH AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (212) 582-3950 MAIL ADDRESS: STREET 1: 810 SEVENTH AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 4 1 doc1.xml FORM 4 X0303 4 2010-03-03 0 0001001316 MANHATTAN PHARMACEUTICALS INC MHAN 0001304506 McGuinness Michael C/O MANHATTAN PHARMACEUTICALS, INC. 48 WALL STREET, SUITE 1110 NEW YORK NY 10005 0 1 0 0 COO & CFO Common Stock 10000 D Stock Options 0.70 2016-07-10 Common Stock 220000 220000 D Stock Options 1.35 2016-07-10 Common Stock 60000 60000 D Stock Options 0.95 2017-04-25 Common Stock 320000 320000 D Stock Options 0.17 2018-03-25 Common Stock 1100000 1100000 D Warrant 0.20 2013-09-10 Common Stock 24000 24000 D Stock Options 0.07 2010-03-03 4 A 0 2000000 0 A 2020-03-02 Common Stock 2000000 2000000 D The option vested as to 73,334 shares on July 10, 2007, and as to 73,333 shares on each of July 10, 2008 and July 10, 2009. The option vested as to 20,000 shares on each of July 10, 2007, July 10, 2008 and July 10, 2009. The option vested as to 106,667 shares on each of April 25, 2008 and April 25, 2009. The remaining 106,666 shares are scheduled to vest on April 25, 2010. The option vested as to 366,667 shares on each of March 25, 2008 and March 25, 2009. The remaining 366,666 shares are scheduled to vest on March 25, 2010. The warrant is exercisable immediately. On March 3, 2010, the reporting person was granted an option to purchase 2,000,000 shares of common stock of Manhattan Pharmaceuticals, Inc. under the 2003 Stock Option Plan. The vesting schedule of the option is as follows: (i) 1,000,000 shares vested on the date of grant, (ii) 333,333 shares are scheduled to vest on each of March 3, 2011 and March 3, 2012, and (iii) 333,334 shares are scheduled to vest on March 3, 2013. /s/ Michael G. McGuinness 2010-03-10 -----END PRIVACY-ENHANCED MESSAGE-----